Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Theophylline recalled?

Yes — there is an active recall. 2 ongoing FDA recalls mention Theophylline (5 total). Check the affected lots below.

Most common reason: Dissolution failure (2 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Theophylline. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Theophylline recalls on record

none so far in 2026; 5 on record, newest first
Class II · Moderate risk

Theophylline extended-release tablets 400mg

Failed Dissolution Specifications: Failure results (above) were reported for the Dissolution (by UV) test for commercial annual stability at the long-term shelf life stability interval, wherein the dissolution results do not comply with L3 stage dissolution criteria.

Ongoing Dissolution failure Glenmark Pharmaceuticals Inc., USA NDC 68462-380-01 D-0583-2025
Class II · Moderate risk

Theophylline

OOS results reported for the Dissolution (by UV) test.

Ongoing Dissolution failure Glenmark Pharmaceuticals Inc., USA D-0452-2025
Class II · Moderate risk

Theophylline

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 68462-380-01 D-0485-2021
Class II · Moderate risk

Theophylline

CGMP Deviations: poor manufacturing practices resulted in Labeling: Incorrect or Missing Lot and/or Exp Date, product incorrectly labeled with incorrect lot and expiration date.

Terminated Stability / shelf life Nostrum Laboratories Inc NDC 29033-001-01 D-1059-2020
Class II · Moderate risk

Theophylline Anhydrous active pharmaceutical ingredient packaged…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-925-2015